WARNER CHILCOTT $19.21


17/5/2013 09:17 AM  |  NASDAQ : WCRX  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
4/1/2013 van Zoonen Marinus Johannes President, Europe/Int'l & Mkt. -703 $13.41 -0.48%
3/4/2013 CONNAUGHTON JOHN Director -10,590,608 $13.47 -100.00%
3/1/2013 Ellman Herman Senior V.P., Clinical Devel. -1,666 $13.38 -0.91%
2/28/2013 Fuhrmann Rochelle Senior V.P., Finance -1,728 $13.46 -2.97%
2/28/2013 Boissonneault Roger M CEO & President -18,730 $13.46 -0.80%
2/28/2013 Herendeen Paul Exec. V.P. and CFO -4,674 $13.46 -3.40%
2/28/2013 Halstead Michael Senior V.P., Corp. Development -1,747 $13.46 -3.24%
2/28/2013 Howard Alvin D Sr. V.P., Regulatory Affairs -1,728 $13.46 -1.70%
2/28/2013 Fenton Andrew Senior V.P., CIO -1,390 $13.46 -1.27%
2/28/2013 Cross Leland H Senior V.P., Tech. Operations -1,324 $13.46 -0.64%
2/28/2013 Gilligan Claire A Senior V.P., Quality -2,354 $13.46 -2.94%
2/28/2013 Rodriguez Rama Francisco Senior V.P., Tech. Operations -820 $13.46 -2.62%
2/28/2013 van Zoonen Marinus Johannes President, Europe/Int'l & Mkt. -15,869 $13.46 -9.83%
2/19/2013 Gilligan Claire A Senior V.P., Quality -1,045 $14.53 -1.29%
2/19/2013 Cross Leland H Senior V.P., Tech. Operations -553 $14.53 -0.27%
2/19/2013 Fenton Andrew Senior V.P., CIO -419 $14.53 -0.38%
2/19/2013 Ellman Herman Senior V.P., Clinical Devel. -691 $14.53 -0.38%
2/19/2013 Howard Alvin D Sr. V.P., Regulatory Affairs -767 $14.53 -0.75%
2/19/2013 Boissonneault Roger M CEO & President -7,928 $14.53 -0.34%
2/19/2013 Halstead Michael Senior V.P., Corp. Development -419 $14.53 -0.77%
2/19/2013 Herendeen Paul Exec. V.P. and CFO -1,969 $14.53 -1.41%
2/19/2013 Fuhrmann Rochelle Senior V.P., Finance -767 $14.53 -1.30%
2/19/2013 van Zoonen Marinus Johannes President, Europe/Int'l & Mkt. -2,562 $14.53 -1.94%
2/1/2013 Cross Leland H Senior V.P., Tech. Operations -808 $14.18 -0.42%
2/1/2013 Ellman Herman Senior V.P., Clinical Devel. -1,010 $14.18 -0.60%
2/1/2013 Halstead Michael Senior V.P., Corp. Development -998 $14.18 -2.50%
2/1/2013 Howard Alvin D Sr. V.P., Regulatory Affairs -1,010 $14.18 -1.15%
2/1/2013 Gilligan Claire A Senior V.P., Quality -1,377 $14.18 -2.06%
2/1/2013 Fuhrmann Rochelle Senior V.P., Finance -998 $14.18 -2.24%
2/1/2013 van Zoonen Marinus Johannes President, Europe/Int'l & Mkt. -13,790 $14.18 -9.44%
2/1/2013 Herendeen Paul Exec. V.P. and CFO -2,840 $14.18 -2.72%
2/1/2013 Fenton Andrew Senior V.P., CIO -996 $14.18 -1.04%
2/1/2013 Boissonneault Roger M CEO & President -9,125 $14.18 -0.41%
1/30/2013 Herendeen Paul Exec. V.P. and CFO -2,208 $13.38 -2.07%
1/30/2013 Howard Alvin D Sr. V.P., Regulatory Affairs -591 $13.38 -0.67%
1/30/2013 Cross Leland H Senior V.P., Tech. Operations -465 $13.38 -0.24%
1/30/2013 Gilligan Claire A Senior V.P., Quality -489 $13.38 -0.73%
1/30/2013 Fenton Andrew Senior V.P., CIO -351 $13.38 -0.37%
1/30/2013 Ellman Herman Senior V.P., Clinical Devel. -586 $13.38 -0.35%
1/30/2013 Fuhrmann Rochelle Senior V.P., Finance -282 $13.38 -0.63%
1/30/2013 Halstead Michael Senior V.P., Corp. Development -320 $13.38 -0.80%
1/30/2013 van Zoonen Marinus Johannes President, Europe/Int'l & Mkt. -1,907 $14.42 -1.29%
1/30/2013 van Zoonen Marinus Johannes President, Europe/Int'l & Mkt. -308 $13.38 -0.21%
1/30/2013 Boissonneault Roger M CEO & President -8,470 $13.38 -0.38%
1/22/2013 Herendeen Paul Exec. V.P. and CFO -4,305 $13.50 -3.88%
1/22/2013 Halstead Michael Senior V.P., Corp. Development -488 $13.50 -1.20%
1/22/2013 Fuhrmann Rochelle Senior V.P., Finance -488 $13.50 -1.08%
1/22/2013 Cross Leland H Senior V.P., Tech. Operations -839 $13.50 -0.43%
1/22/2013 Howard Alvin D Sr. V.P., Regulatory Affairs -1,222 $13.50 -1.36%
1/22/2013 Gilligan Claire A Senior V.P., Quality -949 $13.50 -1.39%
1/22/2013 Ellman Herman Senior V.P., Clinical Devel. -1,166 $13.50 -0.68%
1/22/2013 Fenton Andrew Senior V.P., CIO -621 $13.50 -0.64%
1/22/2013 Boissonneault Roger M CEO & President -13,924 $13.50 -0.62%
11/28/2012 Murray Stephen P Director -6,491,618 $11.41 -100.00%
11/20/2012 Murray Stephen P Director -5,000,000 $11.66 -43.51%
10/1/2012 Halstead Michael Senior V.P., Corp. Development -77 $13.55 -0.19%
10/1/2012 Gilligan Claire A Senior V.P., Quality -264 $13.55 -0.38%
9/11/2012 JPMP MASTER FUND MANAGER L P Substantial Shareholder -193,470 $13.10 -68.93%
9/11/2012 JPMP MASTER FUND MANAGER L P Substantial Shareholder -950,124 $13.10 -54.92%
9/11/2012 JPMP MASTER FUND MANAGER L P Substantial Shareholder -215,401 $13.10 -54.92%
9/11/2012 JPMP MASTER FUND MANAGER L P Substantial Shareholder -1,497,803 $13.10 -68.93%
9/11/2012 Hara Izumi Senior V.P. -126,993 $13.10 -63.22%
9/11/2012 Herendeen Paul Exec. V.P. and CFO -309,240 $13.10 -73.60%
9/11/2012 Howard Alvin D Sr. V.P., Regulatory Affairs -147,639 $13.10 -62.25%
9/11/2012 Ellman Herman Senior V.P., Clinical Devel. -23,500 $13.10 -12.09%
9/11/2012 Murray Stephen P Director -14,000,000 $13.10 -54.92%
9/11/2012 THL WC (Dutch) B.V. Substantial Shareholder -14,000,000 $13.10 -54.92%
9/11/2012 ABBRECHT TODD M Director -14,000,000 $13.10 -54.92%
9/11/2012 BAIN CAPITAL INVESTORS LLC Substantial Shareholder -12,890,449 $13.10 -52.87%
9/11/2012 CONNAUGHTON JOHN Senior Executive Officer -12,890,449 $13.10 -52.87%
9/11/2012 JPMP MASTER FUND MANAGER L P Substantial Shareholder -1,145,303 $13.10 -54.92%
9/11/2012 JPMP MASTER FUND MANAGER L P Substantial Shareholder -266,987 $13.10 -54.92%
9/11/2012 JPMP MASTER FUND MANAGER L P Substantial Shareholder -373,782 $13.10 -54.92%
9/11/2012 JP MORGAN PARTNERS BHCA LP Substantial Shareholder -14,000,000 $13.10 -54.92%
9/11/2012 JP MORGAN PARTNERS BHCA LP Substantial Shareholder -7,894,814 $13.10 -54.92%
9/11/2012 JP MORGAN PARTNERS BHCA LP Substantial Shareholder -2,224,741 $13.10 -54.92%
9/11/2012 JP MORGAN PARTNERS BHCA LP Substantial Shareholder -373,782 $13.10 -54.92%
9/11/2012 JP MORGAN PARTNERS BHCA LP Substantial Shareholder -266,987 $13.10 -54.92%
9/11/2012 JP MORGAN PARTNERS BHCA LP Substantial Shareholder -193,470 $13.10 -68.93%
9/11/2012 JP MORGAN PARTNERS BHCA LP Substantial Shareholder -1,145,303 $13.10 -54.92%
9/11/2012 JP MORGAN PARTNERS BHCA LP Substantial Shareholder -950,124 $13.10 -54.92%
9/11/2012 JP MORGAN PARTNERS BHCA LP Substantial Shareholder -1,497,803 $13.10 -68.93%
9/11/2012 JP MORGAN PARTNERS BHCA LP Substantial Shareholder -215,401 $13.10 -54.92%
9/11/2012 JPMP MASTER FUND MANAGER L P Substantial Shareholder -14,000,000 $13.10 -54.92%
9/11/2012 JPMP MASTER FUND MANAGER L P Substantial Shareholder -7,894,814 $13.10 -54.92%
9/11/2012 JPMP MASTER FUND MANAGER L P Substantial Shareholder -2,224,741 $13.10 -54.92%
7/2/2012 Halstead Michael Senior V.P., Corp. Development -355 $17.96 -0.86%
3/1/2012 Hara Izumi Sr. VP, Gen. Counsel & Sec. -710 $17.00 -0.35%
3/1/2012 Gilligan Claire A Senior V.P., Quality -973 $17.00 -1.40%
3/1/2012 Fenton Andrew Senior V.P., CIO -386 $17.00 -0.40%
3/1/2012 Cross Leland H Senior V.P., Tech. Operations -558 $17.00 -0.29%
3/1/2012 Howard Alvin D Sr. V.P., Regulatory Affairs -710 $17.00 -0.30%
3/1/2012 Fuhrmann Rochelle Senior V.P., Finance -710 $17.00 -1.54%
3/1/2012 Halstead Michael Senior V.P., Corp. Development -725 $17.00 -1.73%
3/1/2012 van Zoonen Marinus Johannes President, Europe/Int'l & Mkt. -2,485 $17.00 -1.64%
3/1/2012 Herendeen Paul Exec. V.P. and CFO -1,827 $17.00 -0.43%
3/1/2012 Boissonneault Roger M CEO & President -5,320 $17.00 -0.24%
2/21/2012 Howard Alvin D Sr. V.P., Regulatory Affairs -752 $16.82 -0.32%
2/21/2012 Hara Izumi Sr. VP, Gen. Counsel & Sec. -752 $16.82 -0.37%
2/21/2012 Gilligan Claire A Senior V.P., Quality -1,030 $16.82 -1.46%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (WCRX), click here.
Marketplace
Trading Center